Dapagliflozin Shown to Slow Diabetic Kidney Disease Progression
Protective effect is driven largely by a sustained 40% decrease in estimate glomerular filtration rate to below 60 mL/min/1.73 m2.
Diabetes Mellitus
FDA Grants Priority Review for Canagliflozin to Treat CKD in T2DM
If approved, canagliflozin would be the first drug in almost 20 years indicated to treat CKD in patients with type 2 diabetes when added to current standard of care, according to the drug’s maker.
GFR Decline Tied to Protein Intake in Diabetic Blacks
The percentage decline in estimated glomerular filtration rate over an 8-year period was greater among those with vs without diabetes across all quintiles of protein intake.
Delayed-release Niacin Benefits Prediabetes, Diabetes
Delayed-release Niacin may be beneficial to patients with prediabetes and type 2 diabetes.
Pre-Op Liraglutide Reduces Post-Op Plasma Glucose in Diabetes Pts
In patients with T2DM, taking liraglutide before surgery may be associated with reduced post-op plasma glucose levels.
FDA Approves Short Acting Insulin Drug for Diabetes
The FDA just approved a new short-acting insulin drug, Admelog, for patients with either T1D or T2D.
Primary Care-led Weight Loss Leads to T2DM Remission
Remission was linked to 46% patients in intensive weight management programs.
FDA Approves Semiglutide for Type 2 Diabetes
Semaglutide helps patients with diabetes reduce blood glucose levels and lower body weight.
Antibiotic-Diabetes Link Questioned
Lifestyle and clinical factors could have been misinterpreted, linking antibiotics to risk of diabetes.
Greater Adherence With Certain Type 2 Diabetes Meds
Sulfonylureas and thiazolidinediones adherence was stronger than metformin adherence.
